Clinical Trial Update: A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

ClinicalTrials.gov entry notes a Phase 1 study of XB628 in participants with recurrent advanced or metastatic solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• XB628

Snippet

Sponsor: Exelixis | Conditions: Solid Tumor, Advanced Solid Tumor | Phase 1 | Status: RECRUITING